ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Operations & Power
Members focus on the dissemination of knowledge and information in the area of power reactors with particular application to the production of electric power and process heat. The division sponsors meetings on the coverage of applied nuclear science and engineering as related to power plants, non-power reactors, and other nuclear facilities. It encourages and assists with the dissemination of knowledge pertinent to the safe and efficient operation of nuclear facilities through professional staff development, information exchange, and supporting the generation of viable solutions to current issues.
Meeting Spotlight
2024 ANS Winter Conference and Expo
November 17–21, 2024
Orlando, FL|Renaissance Orlando at SeaWorld
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2024
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
December 2024
Nuclear Technology
Fusion Science and Technology
November 2024
Latest News
NRC okays construction permits for Hermes 2 test facility
The Nuclear Regulatory Commission announced yesterday that it has directed staff to issue construction permits to Kairos Power for the company's proposed Hermes 2 nonpower test reactor facility to be built at the Heritage Center Industrial Park in Oak Ridge, Tenn. The permits authorize Kairos to build a facility with two 35-MWt test reactors that would use molten salt to cool the reactor cores.
Jisue Moon, Kristian Myhre, Hunter Andrews, Joanna McFarlane
Nuclear Technology | Volume 209 | Number 6 | June 2023 | Pages 787-808
Critical Review | doi.org/10.1080/00295450.2022.2158666
Articles are hosted by Taylor and Francis Online.
Technitium-99m (99mTc), a widely used radioisotope, is used in tens of millions of medical diagnostic procedures annually. However, it is hard to store and must be immediately used upon production due to its short half-life (i.e., 6 h); thus, it is currently produced from 99Mo, which itself is a result of 235U fission. The majority of 99Mo supplies to U.S. patients are currently provided by foreign producers and produced using highly enriched uranium (HEU). In order to minimize the proliferation risks of HEU-based medical isotope production, the U.S. Department of Energy’s National Nuclear Security Administration has funded a program to accelerate the development of technologies to produce 99Mo without the use of HEU.
Today, the global supply of 99Mo depends on a limited number of nuclear reactors, and production has been interrupted unexpectedly since 2009 due to the fleet’s advanced age. Alternative options for 99Mo production are discussed in this paper, and one potential option is to obtain 99mTc from molten salt reactors (MSRs). A MSR is a nuclear fission reactor that can operate at or close to atmospheric pressure with liquid fuel, which allows for producing isotopes in a timely manner. In this paper, the past and current production of 99Mo via nuclear reactors is described, and the future of 99Mo production by MSRs is discussed. The behavior and chemical properties of molybdenum in fluoride salts in MSRs and the possible extraction methods are also examined in addition to the limitation of current studies.
